Experts OK 5-year Intervals Between Colonoscopies for Patients with Inflammatory Bowel Disease

Article

After much debate, waiting five years between colonoscopy procedures for low risk colorectal cancer (CRC) patients has recently been deemed acceptable by disease authorities.

After much debate, waiting five years between colonoscopy procedures for low risk colorectal cancer (CRC) patients has recently been deemed acceptable by disease authorities.

According to a study published in the journal Clinical Gastroenterology and Hepatology, a team of researchers led by Bas Oldenburg, MD, PhD, University Medical Center Utrecht, analyzed data on 1,273 IBD patients (34% Crohn’s disease, 63% ulcerative colitis, and 3% unclassified) who had experienced a total of 4,327 surveillance colonoscopies between January 1, 2000 and January 1, 2014.

Upon monitoring the patients’ first and last surveillance colonoscopies, the team discovered 1.3% of the patient cohort developed CRC — the median interval between the last colonoscopy and CRC diagnosis was 22 months.

The team made sure to categorize which factors could have contributed to CRC occurrence (inadequate procedures, inadequate surveillance, or inadequate dysplasia management). This, in turn, meant the remaining five CRC cases (30%) were considered true interval CRCs.

Oldenburg and team concluded, “In a retrospective analysis of patients with IBD participating in a surveillance program, the incidence of CRC was only 1%, which supports the implementation of longer surveillance intervals. However, the fact that 30% of CRC cases were interval cancers indicates the need for variable surveillance intervals based on risk factors for CRC.”

Related Videos
Timothy Wilt, MD, MPH | Credit: ACP
Square thumbnail featuring headshots of Gursimran Kochhar, MD; Frank Colangelo, MD; Thomas Imperiale, MD; and Michael Sapienza
Square thumbnail featuring headshots of Gursimran Kochhar, MD; Frank Colangelo, MD; Thomas Imperiale, MD; and Michael Sapienza
Square thumbnail featuring headshots of Gursimran Kochhar, MD; Frank Colangelo, MD; Thomas Imperiale, MD; and Michael Sapienza
Square thumbnail featuring headshots of Gursimran Kochhar, MD; Frank Colangelo, MD; Thomas Imperiale, MD; and Michael Sapienza
Square thumbnail featuring headshots of Gursimran Kochhar, MD; Frank Colangelo, MD; Thomas Imperiale, MD; and Michael Sapienza
Taha Qazi, MD | Credit: Cleveland Clinic
Taha Qazi, MD | Credit: Cleveland Clinic
Taha Qazi, MD | Cleveland Clinic
© 2024 MJH Life Sciences

All rights reserved.